CD47 Protein Products for Cancer & Cardiovascular Research

Product News   Sep 12, 2017

 
CD47 Protein Products for Cancer & Cardiovascular Research

Image Credit: AMSBIO

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Next-Generation Sequencing

Product News

New product line leverages established DNA synthesis platform to revolutionize exome and custom sequencing.

READ MORE

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News

Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy.

READ MORE

QIAGEN’s QuantiFERON-TB Gold Plus Gains Approval in Japan

Product News

QIAGEN N.V. announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE